Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Deloitte
Chubb
US Department of Justice
Federal Trade Commission
Mallinckrodt
Dow
Johnson and Johnson
McKesson

Generated: May 27, 2018

DrugPatentWatch Database Preview

CYCLAINE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Cyclaine, and what generic alternatives are available?

Cyclaine is a drug marketed by Merck and is included in one NDA.

The generic ingredient in CYCLAINE is hexylcaine hydrochloride. Additional details are available on the hexylcaine hydrochloride profile page.
Summary for CYCLAINE
US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: 7
Patent Applications: 104
DailyMed Link:CYCLAINE at DailyMed
Drug patent expirations by year for CYCLAINE
Synonyms for CYCLAINE
(2-(Benzoyloxy)propyl)cyclohexylammonium chloride
1-(Cyclohexylamino)-2-propanol benzoate (ester) hydrochloride
1-(cyclohexylamino)propan-2-yl benzoate hydrochloride
2-Propanol, 1-(cyclohexylamino)-, benzoate (ester), hydrochloride
532-76-3
532-77-4 (Parent)
AC1L2SRJ
API0009282
Benzoic acid, (2-(cyclohexylamino)-1-methyl)ethyl ester, hydrochloride
CAS-532-76-3
CCG-220788
CHEMBL1200715
Cyclaine (TN)
D 109
D02454
DSSTox_CID_25321
DSSTox_GSID_45321
DSSTox_RID_80800
DTXSID6045321
EINECS 208-544-2
Hexylcaine HCl
Hexylcaine hydrochloride
HEXYLCAINEHYDROCHLORIDE
HMS1570M18
LS-121962
MLS002154000
NCGC00016495-01
NCGC00179382-03
SCHEMBL24192
SMR001233331
SR-01000841236
SR-01000841236-2
Tox21_110456
Tox21_110456_1

US Patents and Regulatory Information for CYCLAINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck CYCLAINE hexylcaine hydrochloride SOLUTION;TOPICAL 008472-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Merck
Healthtrust
Cipla
Dow
Daiichi Sankyo
Baxter
Chinese Patent Office
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.